SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
学啊学啊发发
Lv1
10 积分
2024-05-16 加入
最近求助
最近应助
互助留言
Safety of Empagliflozin: An Individual Participant-Level Data Meta-Analysis from Four Large Trials
2天前
已完结
Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study
2天前
已完结
Current status and future trends of the global burden of MASLD
4天前
已完结
Prevalence and incidence of MAFLD and associated anthropometric parameters among prepubertal children of the Shanghai Birth Cohort
4天前
已完结
Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study
4天前
已完结
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes
8天前
已完结
Multiparametric US for Identifying Metabolic Dysfunction–associated Steatohepatitis: A Prospective Multicenter Study
8天前
已完结
Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone
10天前
已完结
Targeting EFHD2 Inhibits Interferon-γ Signaling and Ameliorates Non-Alcoholic Steatohepatitis
10天前
已完结
NIS2+ as a screening tool to optimize patient selection in metabolic dysfunction–associated steatohepatitis clinical trials
10天前
已完结
没有进行任何应助
1.文章标题与“代谢相关(非酒精性)脂肪性肝病防治指南(2024年版)”不同;2.文章来源也不同,该指南来自于《中华肝脏病杂志》
8天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论